Furthermore, the panel felt that if CRP POC testing becomes mandatory even in clear-cut cases requiring antibiotic prescription (e.g., radiographically confirmed pneumonia, purulent COPD exacerbation), there would likely be backlash from providers over a perceived lack of trust in their clinical assessment. The gene discussed is CRP; the disease is pneumonia.